User profiles for Samuel Katsuyuki Shinjo

Samuel Katsuyuki Shinjo

Rheumatology Division - Faculdade de Medicina da USP - Sao Paulo
Verified email at usp.br
Cited by 4909

2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis …

…, S Katsuyuki Shinjo… - Arthritis & …, 2017 - Wiley Online Library
Objective To develop response criteria for adult dermatomyositis (DM) and polymyositis (PM).
Methods Expert surveys, logistic regression, and conjoint analysis were used to develop …

[HTML][HTML] Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and …

…, VST Viana, M Levy-Neto, FHC Souza, SK Shinjo - Clinics, 2013 - SciELO Brasil
OBJECTIVE: To analyze the prevalence of myositis-specific and myositis-associated
autoantibodies and their clinical correlations in a large series of patients with dermatomyositis/…

Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID‐19: a prospective observational study

S Gil, W Jacob Filho, SK Shinjo… - Journal of cachexia …, 2021 - Wiley Online Library
Background Strength and muscle mass are predictors of relevant clinical outcomes in critically
ill patients, but in hospitalized patients with COVID‐19, it remains to be determined. In this …

[HTML][HTML] Safety and possible effects of low-intensity resistance training associated with partial blood flow restriction in polymyositis and dermatomyositis

MA Mattar, B Gualano, LA Perandini, SK Shinjo… - Arthritis research & …, 2014 - Springer
Introduction Our aim was to evaluate the safety and efficacy of a low-intensity resistance
training program combined with partial blow flow restriction (BFR training) in a cohort of patients …

[HTML][HTML] COVID-19 vaccination in autoimmune disease (COVAD) survey protocol

…, AL Tan, L Cavagna, MA Saavedra, SK Shinjo… - Rheumatology …, 2022 - Springer
The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented
global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only …

COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies

…, L Cavagna, MA Saavedra, SK Shinjo… - Muscle & …, 2022 - Wiley Online Library
Introduction/Aims In this study we investigated COVID‐19 vaccination–related adverse
events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory myopathies (IIMs) …

Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases

…, PT Rojo, RMR Pereira, SK Shinjo… - Annals of the …, 2022 - ard.bmj.com
Objective To determine the immunogenicity of the third dose of CoronaVac vaccine in a
large population of patients with autoimmune rheumatic diseases (ARD) and the factors …

[HTML][HTML] Applications of non-invasive neuromodulation for the management of disorders related to COVID-19

…, RJ Duarte-Moreira, RL Pagano, SK Shinjo… - Frontiers in …, 2020 - frontiersin.org
Background: Novel coronavirus disease (COVID-19) morbidity is not restricted to the
respiratory system, but also affects the nervous system. Non-invasive neuromodulation may be …

[HTML][HTML] COVAD survey 2 long-term outcomes: unmet need and protocol

…, L Cavagna, MA Saavedra, SK Shinjo… - Rheumatology …, 2022 - Springer
Vaccine hesitancy is considered a major barrier to achieving herd immunity against COVID-19.
While multiple alternative and synergistic approaches including heterologous vaccination…

Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or …

…, FH Carlos de Souza, EF Borba, SK Shinjo - Clinical …, 2014 - Springer
Because overlap syndromes (OSs) are rarely described, we analyzed retrospectively their
frequencies and correlations in Brazilian series of 31 patients with dermatomyositis (DM)/…